Cargando…

A patient-specific treatment model for Graves’ hyperthyroidism

BACKGROUND: Graves’ is disease an autoimmune disorder of the thyroid gland caused by circulating anti-thyroid receptor antibodies (TRAb) in the serum. TRAb mimics the action of thyroid stimulating hormone (TSH) and stimulates the thyroid hormone receptor (TSHR), which results in hyperthyroidism (ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandiyan, Balamurugan, Merrill, Stephen J., Bari, Flavia Di, Antonelli, Alessandro, Benvenga, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759289/ https://www.ncbi.nlm.nih.gov/pubmed/29310665 http://dx.doi.org/10.1186/s12976-017-0073-6

Ejemplares similares

Thyroid vascularization is an important ultrasonographic parameter in untreated Graves’ disease patients
por: Vita, Roberto, et al.
Publicado: (2019)

The various faces of hyperthyroidism
por: Koch, Christian A., et al.
Publicado: (2020)

Serum Thyrotropin and Phase of the Menstrual Cycle
por: Benvenga, Salvatore, et al.
Publicado: (2017)

Current and emerging treatment options for Graves’ hyperthyroidism
por: Abraham, Prakash, et al.
Publicado: (2010)

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
por: Lanzolla, Giulia, et al.
Publicado: (2021)

MON-594 Report Of A Large Series Of Patients With Graves' Disease (with/without Graves' Ophthalmopathy) And Review Of The Literature, About The Association With Other Autoimmune Diseases
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Alternating hyperthyroidism and hypothyroidism in Graves’ disease
por: Wong, Mimi, et al.
Publicado: (2018)

The importance of an individual approach to Graves’ hyperthyroidism
por: Bednarczuk, Tomasz
Publicado: (2015)

New Therapeutic Horizons for Graves’ Hyperthyroidism
por: Lane, Laura C, et al.
Publicado: (2020)

R-CHOP-Associated Graves' Hyperthyroidism
por: Mora, Natalie, et al.
Publicado: (2019)

Toward Ultimate Care for Graves’ Hyperthyroidism
por: Azizi, Fereidoun, et al.
Publicado: (2019)

The Grave Hematologic and Hepatic Effects of Hyperthyroidism
por: Ahmad, Sara Miriam, et al.
Publicado: (2021)

Precision Medicine in Graves’ Disease and Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2021)

Graves’ hyperthyroidism in pregnancy: a clinical review
por: Nguyen, Caroline T., et al.
Publicado: (2018)

Hyperthyroidism and Graves’ disease: Is an ultrasound examination needed?
por: Varadhan, Lakshminarayanan, et al.
Publicado: (2016)

The Influence of Prior Hyperthyroidism on Euthyroid Graves' Ophthalmopathy
por: Termote, Karolien, et al.
Publicado: (2014)

Thyroid Function after Subtotal Thyroidectomy in Patients with Graves' Hyperthyroidism
por: Limonard, E. J., et al.
Publicado: (2012)

Selective use of vandetanib in the treatment of thyroid cancer
por: Fallahi, Poupak, et al.
Publicado: (2015)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
por: Le Moli, Rosario, et al.
Publicado: (2020)

Radioiodine Thyroid Ablation in Graves’ Hyperthyroidism: Merits and Pitfalls
por: Nwatsock, J. F., et al.
Publicado: (2012)

Graves’ orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model
por: Schlüter, Anke, et al.
Publicado: (2018)

Worsening of pretibial myxedema following radioiodine treatment for hyperthyroid Graves’ disease
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2023)

A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
por: Doi, Suhail AR, et al.
Publicado: (2001)

Pancytopenia with cellular bone marrow related to Graves’ hyperthyroidism
por: Raina, Sujeet, et al.
Publicado: (2012)

COVID-19: a cause of recurrent Graves’ hyperthyroidism?
por: Jiménez-Blanco, S., et al.
Publicado: (2020)

Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism
por: Abbara, Ali, et al.
Publicado: (2020)

Unilateral gynecomastia as an initial presentation of hyperthyroid Graves’ disease
por: Sakulterdkiat, Titipatima, et al.
Publicado: (2021)

Urticarial vasculitis in a young woman with Graves hyperthyroidism
por: Hung, Yi-Teng, et al.
Publicado: (2022)

AZD-1222: Aggravation of Graves hyperthyroidism: case report
Publicado: (2022)

Hyperthyroidism Due to Graves Disease After Radiofrequency Ablation
por: McAninch, Elizabeth A, et al.
Publicado: (2023)

Clinical diagnosis of Graves’ or non-Graves’ hyperthyroidism compared to TSH receptor antibody test
por: Bell, Lauren, et al.
Publicado: (2018)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

The Synergistic Effect of Corticosteroids and Mycophenolic Acid on Chemokines in Orbital Cells From Patients With Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

Effects of treatment modalities for Graves’ hyperthyroidism on Graves’ orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement
por: Bartalena, L., et al.
Publicado: (2015)

Risk factors of hepatic dysfunction in patients with Graves’ hyperthyroidism and the efficacy of (131)iodine treatment
por: Wang, Renfei, et al.
Publicado: (2017)

Simultaneous induction of Graves’ hyperthyroidism and Graves’ ophthalmopathy by TSHR genetic immunization in BALB/c mice
por: Xia, Nan, et al.
Publicado: (2017)

Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study
por: Pearce, Simon H.S., et al.
Publicado: (2019)

Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic
por: Bartalena, L., et al.
Publicado: (2020)

Tozinameran: Recurrence of hyperthyroidism secondary to Graves' disease: case report
Publicado: (2021)

Prediction for recurrence following antithyroid drug therapy for Graves’ hyperthyroidism
por: Weng, Huan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vdct2u24tacj90drohkppd5870